These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11150018)

  • 21. B cells may propagate prions.
    Vogel G
    Science; 1997 Dec; 278(5346):2050. PubMed ID: 9432715
    [No Abstract]   [Full Text] [Related]  

  • 22. A highly specific blood test for vCJD.
    Jackson GS; Burk-Rafel J; Edgeworth JA; Sicilia A; Abdilahi S; Korteweg J; Mackey J; Thomas C; Wang G; Mead S; Collinge J
    Blood; 2014 Jan; 123(3):452-3. PubMed ID: 24434999
    [No Abstract]   [Full Text] [Related]  

  • 23. Creutzfeldt-Jakob disease: blood infectivity and screening tests.
    Brown P
    Semin Hematol; 2001 Oct; 38(4 Suppl 9):2-6. PubMed ID: 11685719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
    Ironside JW; Head MW
    Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I/II safety study of transfusion of prion-filtered red cell concentrates in transfusion-dependent patients.
    Cahill MR; Murphy T; Khan M; Fagan J; Murphy WG
    Vox Sang; 2010 Aug; 99(2):174-6. PubMed ID: 20345513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of cellular prion protein on platelets from patients with gray platelet or Hermansky-Pudlak syndrome and the protein's association with alpha-granules.
    Holada K; Glierova H; Simak J; Vostal JG
    Haematologica; 2006 Aug; 91(8):1126-9. PubMed ID: 16885055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical considerations in presymptomatic testing for variant CJD.
    Duncan RE; Delatycki MB; Collins SJ; Boyd A; Masters CL; Savulescu J
    J Med Ethics; 2005 Nov; 31(11):625-30. PubMed ID: 16269554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
    Basu A
    Nepal Med Coll J; 2003 Jun; 5(1):51-2. PubMed ID: 16583978
    [No Abstract]   [Full Text] [Related]  

  • 29. Prion reduction of red-blood-cells.
    Coste J; Prowse C; Grabmer C; Schennach H; Santos Prado Scuracchio P; Wendel SN; Germain M; Delage G; Krusius T; Ekblom-Kullberg S; Tiberghien P; O'Riordan J; Murphy WG; Flesland O; Turner M; Williamson L; Gregori L; Epstein J; Asher D; Panzer S; Reesink HW
    Vox Sang; 2012 Oct; 103(3):260-72. PubMed ID: 22519941
    [No Abstract]   [Full Text] [Related]  

  • 30. Pressure grows over US blood ban.
    Goodman S
    Nature; 2001 Aug; 412(6846):467. PubMed ID: 11484010
    [No Abstract]   [Full Text] [Related]  

  • 31. [A new putative principle for diagnosis of Creutzfeldt-Jakob disease].
    Sjögren M; Blennow K
    Lakartidningen; 2002 May; 99(21):2382-4. PubMed ID: 12090164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Charity's new business. Red Cross for-profit venture targets mad cow pathogens.
    Becker C
    Mod Healthc; 2002 Apr; 32(16):22. PubMed ID: 12001567
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy.
    Arya SC
    Lancet; 1997 May; 349(9061):1322-3. PubMed ID: 9142081
    [No Abstract]   [Full Text] [Related]  

  • 34. Creutzfeldt-Jakob disease.
    Oney D
    Pulse; 1999; 36(2):22. PubMed ID: 10614475
    [No Abstract]   [Full Text] [Related]  

  • 35. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 36. Creutzfeldt-Jakob disease.
    Clement P
    Haemophilia; 2000 Jul; 6 Suppl 1():68-78. PubMed ID: 10982271
    [No Abstract]   [Full Text] [Related]  

  • 37. Can CJD be transmitted through the blood supply.
    Larke B
    CMAJ; 1998 Mar; 158(6):714-5. PubMed ID: 9538848
    [No Abstract]   [Full Text] [Related]  

  • 38. Consensus statement on the bio-safety of urinary-derived gonadotrophins with respect to Creutzfeldt-Jakob disease.
    Balen AH; Lumholtz IB
    Hum Reprod; 2005 Nov; 20(11):2994-9. PubMed ID: 16055457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New variant CJD fears threaten blood supplies.
    Senior K
    Lancet; 2001 Jul; 358(9278):304. PubMed ID: 11498226
    [No Abstract]   [Full Text] [Related]  

  • 40. Japan plans blood-donor restrictions to combat vCJD.
    Fuyuno I
    Nature; 2005 Mar; 434(7031):260. PubMed ID: 15772611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.